Glenmark Pharmaceuticals P/E Ratio

Current P/E Ratio
51.4
High Valuation
Very High - High growth expectations or significantly overvalued

Glenmark Pharmaceuticals P/E ratio. Glenmark Pharmaceuticals (GLENMARK) P/E ratio is 51.4 (High), EPS (TTM) ₹48.26, current price ₹2608.50 on NSE vs historical average P/E of 22.92 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Check GLENMARK company valuation to track the company's total market size over time.

Current Valuation Metrics

P/E Ratio 51.4
Current Price ₹2608.50
EPS (TTM) ₹48.26
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 22.92
Historical Range 10.2 - 42.78
Percentile 100.0%

Sector Context

Sector Average 52.2
Sector Median 29.4
Sector Rank #11 of 255
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹58.77
Sept 2026 ₹9.35
Mar 2026 ₹10.68

GLENMARK P/E Ratio — Valuation Signal & Historical Context

Glenmark Pharmaceuticals P/E 51.4 vs historical average 22.92, range 10.2–42.78 — signal: Overvalued. Also explore GLENMARK share price charts to track price trends across different timeframes.

  • Stock appears overvalued with PE of 51.4, suggesting caution for new investments
  • Current PE is 124.2% above historical average

Glenmark Pharmaceuticals P/E Ratio Historical Trend

GLENMARK annual price-to-earnings ratio — 8 years, EPS and year-end price. Current P/E 51.4 vs historical average 22.92. For live price, revenue and the complete fundamental profile, see Glenmark Pharmaceuticals share price today.

GLENMARK Historical P/E Ratio — EPS, Year-End Price & Valuation

Glenmark Pharmaceuticals annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 42.78 37.74 ₹1614.50 NSE High
2022 16.82 31.22 ₹525.25 NSE Moderate
2021 13.91 36.14 ₹502.60 NSE Low
2020 10.2 33.9 ₹345.70 NSE Low
2019 27.23 25.42 ₹692.15 NSE High
2018 18.39 32.42 ₹596.10 NSE Moderate
2017 29.84 29.62 ₹884.00 NSE High
2016 24.21 38.15 ₹923.75 NSE Moderate

GLENMARK vs Healthcare Peers — P/E Ratio Comparison

Glenmark Pharmaceuticals P/E 51.4 vs Healthcare average 52.2, median 29.4 — range 2.0–733.0.

Sector Average
52.2
Sector Median
29.4
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low